AAAAAA

   
Results: 1-19 |
Results: 19
ERBB-2 AND RESPONSE TO DOXORUBICIN IN PATIENTS WITH AXILLARY LYMPH NODE-POSITIVE, HORMONE RECEPTOR-NEGATIVE BREAST-CANCER
Authors: PAIK SM BRYANT J PARK CH FISHER B TANCHIU E HYAMS D FISHER ER LIPPMAN ME WICKERHAM DL WOLMARK N
Citation: Sm. Paik et al., ERBB-2 AND RESPONSE TO DOXORUBICIN IN PATIENTS WITH AXILLARY LYMPH NODE-POSITIVE, HORMONE RECEPTOR-NEGATIVE BREAST-CANCER, Journal of the National Cancer Institute, 90(18), 1998, pp. 1361-1370
TAMOXIFEN FOR PREVENTION OF BREAST-CANCER - REPORT OF THE ATIONAL-SURGICAL-ADJUVANT-BREAST-AND-BOWEL-PROJECT P-1 STUDY
Authors: FISHER B COSTANTINO JP WICKERHAM DL REDMOND CK KAVANAH M CRONIN WM VOGEL V ROBIDOUX A DIMITROV N ATKINS J DALY M WIEAND S TANCHIU E FORD L WOLMARK N
Citation: B. Fisher et al., TAMOXIFEN FOR PREVENTION OF BREAST-CANCER - REPORT OF THE ATIONAL-SURGICAL-ADJUVANT-BREAST-AND-BOWEL-PROJECT P-1 STUDY, Journal of the National Cancer Institute, 90(18), 1998, pp. 1371-1388
NSABP PROTOCOL B-06 - A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER - RESULTS AFTER 15 YEARS OF FOLLOW-UP
Authors: WICKERHAM DL ANDERSON SA FISHER B MARGOLESE R MAMOUNAS T WOLMARK N
Citation: Dl. Wickerham et al., NSABP PROTOCOL B-06 - A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER - RESULTS AFTER 15 YEARS OF FOLLOW-UP, European journal of cancer, 34, 1998, pp. 152-152
EFFECT OF PREOPERATIVE CHEMOTHERAPY ON THE OUTCOME OF WOMEN WITH OPERABLE BREAST-CANCER
Authors: FISHER B BRYANT J WOLMARK N MAMOUNAS E BROWN A FISHER ER WICKERHAM DL BEGOVIC M DECILLIS A ROBIDOUX A MARGOLESE RG CRUZ AB HOEHN JL LEES AW DIMITROV NV BEAR HD
Citation: B. Fisher et al., EFFECT OF PREOPERATIVE CHEMOTHERAPY ON THE OUTCOME OF WOMEN WITH OPERABLE BREAST-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2672-2685
LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWELPROJECT B-17
Authors: FISHER B DIGNAM J WOLMARK N MAMOUNAS E COSTANTINO J POLLER W FISHER ER WICKERHAM DL DEUTSCH M MARGOLESE R DIMITROV N KAVANAH M
Citation: B. Fisher et al., LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWELPROJECT B-17, Journal of clinical oncology, 16(2), 1998, pp. 441-452
TAMOXIFEN AND CHEMOTHERAPY FOR LYMPH NODE-NEGATIVE, ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER
Authors: FISHER B DIGNAM J WOLMARK N DECILLIS A EMIR B WICKERHAM DL BRYANT J DIMITROV NV ABRAMSON N ATKINS JN SHIBATA H DESCHENES L MARGOLESE RG
Citation: B. Fisher et al., TAMOXIFEN AND CHEMOTHERAPY FOR LYMPH NODE-NEGATIVE, ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 89(22), 1997, pp. 1673-1682
AGGRESSIVENESS OF COLON-CARCINOMA IN BLACKS AND WHITES
Authors: CHEN VW FENOGLIOPREISER CM WU XC COATES RJ REYNOLDS P WICKERHAM DL ANDREWS P HUNTER C STEMMERMANN G JACKSON JS EDWARDS BK
Citation: Vw. Chen et al., AGGRESSIVENESS OF COLON-CARCINOMA IN BLACKS AND WHITES, Cancer epidemiology, biomarkers & prevention, 6(12), 1997, pp. 1087-1093
EFFECT OF PREOPERATIVE CHEMOTHERAPY ON LOCAL-REGIONAL DISEASE IN WOMEN WITH OPERABLE BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-18
Authors: FISHER B BROWN A MAMOUNAS E WIEAND S ROBIDOUX A MARGOLESE RG CRUZ AB FISHER ER WICKERHAM DL WOLMARK N DECILLIS A HOEHN JL LEES AW DIMITROV NV
Citation: B. Fisher et al., EFFECT OF PREOPERATIVE CHEMOTHERAPY ON LOCAL-REGIONAL DISEASE IN WOMEN WITH OPERABLE BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-18, Journal of clinical oncology, 15(7), 1997, pp. 2483-2493
INCREASED INTENSIFICATION AND TOTAL-DOSE OF CYCLOPHOSPHAMIDE IN A DOXORUBICIN-CYCLOPHOSPHAMIDE REGIMEN FOR THE TREATMENT OF PRIMARY BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-22
Authors: FISHER B ANDERSON S WICKERHAM DL DECILLIS A DIMITROV N MAMOUNAS E WOLMARK N PUGH R ATKINS JN MEYERS FJ ABRAMSON N WOLTER J BORNSTEIN RS LEVY L ROMOND EH CAGGIANO V GRIMALDI M JOCHIMSEN P DECKERS P
Citation: B. Fisher et al., INCREASED INTENSIFICATION AND TOTAL-DOSE OF CYCLOPHOSPHAMIDE IN A DOXORUBICIN-CYCLOPHOSPHAMIDE REGIMEN FOR THE TREATMENT OF PRIMARY BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-22, Journal of clinical oncology, 15(5), 1997, pp. 1858-1869
A CLINICAL-TRIAL TO EVALUATE THE WORTH OF PREOPERATIVE MULTIMODALITY THERAPY IN PATIENTS WITH OPERABLE CARCINOMA OF THE RECTUM - A PROGRESSREPORT OF NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL R-03
Authors: HYAMS DM MAMOUNAS EP PETRELLI N ROCKETTE H JONES J WIEAND HS DEUTSCH M WICKERHAM DL FISHER B WOLMARK N
Citation: Dm. Hyams et al., A CLINICAL-TRIAL TO EVALUATE THE WORTH OF PREOPERATIVE MULTIMODALITY THERAPY IN PATIENTS WITH OPERABLE CARCINOMA OF THE RECTUM - A PROGRESSREPORT OF NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL R-03, Diseases of the colon & rectum, 40(2), 1997, pp. 131-139
5 VERSUS MORE THAN 5 YEARS OF TAMOXIFEN THERAPY FOR BREAST-CANCER PATIENTS WITH NEGATIVE LYMPH-NODES AND ESTROGEN RECEPTOR-POSITIVE TUMORS
Authors: FISHER B DIGNAM J BRYANT J DECILLIS A WICKERHAM DL WOLMARK N COSTANTINO J REDMOND C FISHER ER BOWMAN DM DESCHENES L DIMITROV NV MARGOLESE RG ROBIDOUX A SHIBATA H TERZ J PATERSON AHG FELDMAN MI FARRAR W EVANS J LICKLEY HL
Citation: B. Fisher et al., 5 VERSUS MORE THAN 5 YEARS OF TAMOXIFEN THERAPY FOR BREAST-CANCER PATIENTS WITH NEGATIVE LYMPH-NODES AND ESTROGEN RECEPTOR-POSITIVE TUMORS, Journal of the National Cancer Institute, 88(21), 1996, pp. 1529-1542
SEQUENTIAL METHOTREXATE AND FLUOROURACIL FOR THE TREATMENT OF NODE-NEGATIVE BREAST-CANCER PATIENTS WITH ESTROGEN RECEPTOR-NEGATIVE TUMORS -8-YEAR RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-13 AND FIRST REPORT OF FINDINGS FROM NSABP B-19 COMPARINGMETHOTREXATE AND FLUOROURACIL WITH CONVENTIONAL CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL
Authors: FISHER B DIGNAM J MAMOUNAS EP COSTANTINO JP WICKERHAM DL REDMOND C WOLMARK N DIMITROV NV BOWMAN DM GLASS AG ATKINS JN ABRAMSON N SUTHERLAND CM ARON BS MARGOLESE RG
Citation: B. Fisher et al., SEQUENTIAL METHOTREXATE AND FLUOROURACIL FOR THE TREATMENT OF NODE-NEGATIVE BREAST-CANCER PATIENTS WITH ESTROGEN RECEPTOR-NEGATIVE TUMORS -8-YEAR RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-13 AND FIRST REPORT OF FINDINGS FROM NSABP B-19 COMPARINGMETHOTREXATE AND FLUOROURACIL WITH CONVENTIONAL CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL, Journal of clinical oncology, 14(7), 1996, pp. 1982-1992
REANALYSIS AND RESULTS AFTER 12 YEARS OF FOLLOW-UP IN A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER
Authors: FISHER B ANDERSON S REDMOND CK WOLMARK N WICKERHAM DL CRONIN WM
Citation: B. Fisher et al., REANALYSIS AND RESULTS AFTER 12 YEARS OF FOLLOW-UP IN A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER, The New England journal of medicine, 333(22), 1995, pp. 1456-1461
ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14
Authors: FISHER B COSTANTINO JP REDMOND CK FISHER ER WICKERHAM DL CRONIN WM BOWMAN D COUTURE J DIMITROV NV EVANS J FARRAR W KAVANAH M LICKLEY HL MARGOLESE R PATERSON AHG ROBIDOUX A SHIBATA H TERZ J
Citation: B. Fisher et al., ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14, Journal of the National Cancer Institute, 86(7), 1994, pp. 527-537
ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP)-B-14 - REPLY
Authors: FISHER ER FISHER B WICKERHAM DL COSTANTINO JP REDMOND C
Citation: Er. Fisher et al., ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP)-B-14 - REPLY, Journal of the National Cancer Institute, 86(16), 1994, pp. 1253-1254
ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP)-B-14 - REPLY
Authors: FISHER ER FISHER B WICKERHAM DL COSTANTINO JP REDMOND C
Citation: Er. Fisher et al., ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP)-B-14 - REPLY, Journal of the National Cancer Institute, 86(16), 1994, pp. 1255-1255
THE EFFICACY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PERMITTING THE ADMINISTRATION OF HIGHER DOSES OF CYCLOPHOSPHAMIDE IN A DOXORUBICIN-CYCLOPHOSPHAMIDE COMBINATION - AN NSABP PILOT-STUDY IN PATIENTS WITH METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER
Authors: MAMOUNAS EP ANDERSON S WICKERHAM DL CLARK R STOLLER R HAMM JT STEWART JA BEAR HD GLASS AG BORNSTEIN R FISHER B
Citation: Ep. Mamounas et al., THE EFFICACY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PERMITTING THE ADMINISTRATION OF HIGHER DOSES OF CYCLOPHOSPHAMIDE IN A DOXORUBICIN-CYCLOPHOSPHAMIDE COMBINATION - AN NSABP PILOT-STUDY IN PATIENTS WITH METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER, American journal of clinical oncology, 17(5), 1994, pp. 374-381
THE BENEFIT OF LEUCOVORIN-MODULATED FLUOROURACIL AS POSTOPERATIVE ADJUVANT THERAPY FOR PRIMARY COLON-CANCER - RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL C-03
Authors: WOLMARK N ROCKETTE H FISHER B WICKERHAM DL REDMOND C FISHER ER JONES J MAMOUNAS EP ORE L PETRELLI NJ SPURR CL DIMITROV N ROMOND EH SUTHERLAND CM KARDINAL CG DEFUSCO PA JOCHIMSEN P
Citation: N. Wolmark et al., THE BENEFIT OF LEUCOVORIN-MODULATED FLUOROURACIL AS POSTOPERATIVE ADJUVANT THERAPY FOR PRIMARY COLON-CANCER - RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL C-03, Journal of clinical oncology, 11(10), 1993, pp. 1879-1887
LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER
Authors: FISHER B COSTANTINO J REDMOND C FISHER E MARGOLESE R DIMITROV N WOLMARK N WICKERHAM DL DEUTSCH M ORE L MAMOUNAS E POLLER W KAVANAH M
Citation: B. Fisher et al., LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER, The New England journal of medicine, 328(22), 1993, pp. 1581-1586
Risultati: 1-19 |